EAF2 loss enhances angiogenic effects of von Hippel-Lindau heterozygosity on the murine liver and prostate

Angiogenesis

Volumn 14, Issue 3, 2011, Pages 331-343

  Pascal, Laura E ^a   Ai, Junkui ^a   Rigatti, Lora H ^b   Lipton, Anne K ^a   Xiao, Wuhan ^a,c   Gnarra, James R ^a   Wang, Zhou ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c INSTITUTE OF HYDROBIOLOGY   (China)

Author keywords

ELL associated factor 2 (EAF2); Hepatic vascular lesion; Prostatic intraepithelial neoplasia (PIN); Von Hippel Lindau (VHL)

Indexed keywords

ELL ASSOCIATED FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FIBROSIS; GENE DELETION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; INCIDENCE; INFLAMMATION; LIVER; LIVER INJURY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN BINDING; PROTEIN DEFECT; PROTEIN TARGETING; SMOOTH MUSCLE FIBER; STROMA;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HETEROZYGOTE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; LIVER; MALE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TRANS-ACTIVATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

MURINAE; MUS;

EID: 80052736660     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-011-9217-1     Document Type: Article

References (33)

1. PH Maxwell MS Wiesener GW Chang SC Clifford EC Vaux ME Cockman CC Wykoff CW Pugh ER Maher PJ Ratcliffe 1999 The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 271 275 10353251 10.1038/20459 1:CAS:528:DyaK1MXjsFyqt74%3D (Pubitemid 29246458)
2. M Ohh CW Park M Ivan MA Hoffman TY Kim LE Huang N Pavletich V Chau WG Kaelin 2000 Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein Nat Cell Biol 2 423 427 10878807 10.1038/35017054 1:CAS:528:DC%2BD3cXkvFCqtrk%3D
3. WK Rathmell MC Simon 2005 VHL: oxygen sensing and vasculogenesis J Thromb Haemost 3 2627 2632 15975138 10.1111/j.1538-7836.2005.01441.x 1:STN:280:DC%2BD2Mnntl2nsQ%3D%3D (Pubitemid 41819789)
4. W Liu H Xin DT Eckert JA Brown JR Gnarra 2010 Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor Oncogene 30 21 31 20802534 10.1038/onc.2010.395
5. CJ Hu LY Wang LA Chodosh B Keith MC Simon 2003 Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation Mol Cell Biol 23 9361 9374 14645546 10.1128/MCB.23.24.9361-9374.2003 1:CAS:528:DC%2BD3sXpslGqtbc%3D (Pubitemid 37499822)
6. JR Gnarra JM Ward FD Porter JR Wagner DE Devor A Grinberg MR Emmert-Buck H Westphal RD Klausner WM Linehan 1997 Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice Proc Natl Acad Sci USA 94 9102 9107 9256442 10.1073/pnas.94.17.9102 1:CAS:528:DyaK2sXls1Kmu7s%3D (Pubitemid 27357789)
7. VH Haase JN Glickman M Socolovsky R Jaenisch 2001 Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor Proc Natl Acad Sci USA 98 1583 1588 11171994 10.1073/pnas.98.4.1583 1:CAS:528:DC%2BD3MXhsVWjtbc%3D (Pubitemid 32165542)
8. W Ma L Tessarollo SB Hong M Baba E Southon TC Back S Spence CG Lobe N Sharma GW Maher, et al. 2003 Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene Cancer Res 63 5320 5328 14500363 1:CAS:528:DC%2BD3sXntlektbg%3D (Pubitemid 37139846)
9. E Kleymenova JI Everitt L Pluta M Portis JR Gnarra CL Walker 2004 Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice Carcinogenesis 25 309 315 14604887 10.1093/carcin/bgh017 1:CAS:528:DC%2BD2cXhslWks7s%3D (Pubitemid 38344396)
10. S Chen CA Sanford J Sun V Choi T Van Dyke RJ Samulski WK Rathmell 2010 VHL and PTEN loss coordinate to promote mouse liver vascular lesions Angiogenesis 13 59 69 20221685 10.1007/s10456-010-9164-2
11. EB Rankin JE Tomaszewski VH Haase 2006 Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor Cancer Res 66 2576 2583 16510575 10.1158/0008-5472.CAN-05-3241 1:CAS:528: DC%2BD28XhvV2htbY%3D
12. HC Shen A Adem K Ylaya A Wilson M He D Lorang SM Hewitt K Pechhold DM Harlan IA Lubensky, et al. 2009 Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations PLoS One 4 e4897 19340311 10.1371/journal.pone. 0004897
13. W Xiao J Ai G Habermacher O Volpert X Yang AY Zhang J Hahn X Cai Z Wang 2009 U19/Eaf2 binds to and stabilizes von hippel-lindau protein Cancer Res 69 2599 2606 19258512 10.1158/0008-5472.CAN-08-2595 1:CAS:528:DC%2BD1MXjtFyqu7k%3D
14. Su F, Pascal LE, Xiao W, Wang Z (2009) Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53. Oncogene 29:421-431
15. W Xiao Q Zhang G Habermacher X Yang AY Zhang X Cai J Hahn J Liu M Pins L Doglio, et al. 2008 U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia Oncogene 27 1536 1544 17873910 10.1038/sj.onc.1210786 1:CAS:528: DC%2BD1cXivFyrt7w%3D (Pubitemid 351347870)
16. L Lindstedt PJ Schaeffer 2002 Use of allometry in predicting anatomical and physiological parameters of mammals Lab Anim 36 1 19 11833526 10.1258/0023677021911731 1:CAS:528:DC%2BD38XitFyqsb4%3D (Pubitemid 34073118)
17. Oudes AJ, Campbell DS, Sorensen CM, Walashek LS, True LD, Liu AY (2006) Transcriptomes of human prostate cells. BMC Genom 7:92
18. LE Pascal RZ Vencio LS Page ES Liebeskind CP Shadle P Troisch B Marzolf LD True LE Hood AY Liu 2009 Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes BMC Cancer 9 452 20021671 10.1186/1471-2407-9-452
19. LE Pascal YA Goo RZ Vencio LS Page AA Chambers ES Liebeskind TK Takayama LD True AY Liu 2009 Gene expression down-regulation in CD90 + prostate tumor-associated stromal cells involves potential organ-specific genes BMC Cancer 9 317 19737398 10.1186/1471-2407-9-317
20. RA Irizarry B Hobbs F Collin YD Beazer-Barclay KJ Antonellis U Scherf TP Speed 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 249 264 12925520 10.1093/biostatistics/4.2.249
21. B Marzolf EW Deutsch P Moss D Campbell MH Johnson T Galitski 2006 SBEAMS-microarray: database software supporting genomic expression analyses for systems biology BMC Bioinform 7 286 10.1186/1471-2105-7-286 (Pubitemid 44164749)
22. H Zhong GL Semenza JW Simons AM De Marzo 2004 Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis Cancer Detect Prev 28 88 93 15068831 10.1016/j.cdp.2003.12.009 1:CAS:528:DC%2BD2cXkt12jtL8%3D (Pubitemid 38448745)
23. WJ Huss CF Hanrahan RJ Barrios JW Simons NM Greenberg 2001 Angiogenesis and prostate cancer: identification of a molecular progression switch Cancer Res 61 2736 2743 11289156 1:CAS:528:DC%2BD3MXisVSksbo%3D (Pubitemid 32685863)
24. AP Araujo TF Frezza SM Allegretti S Giorgio 2010 Hypoxia, hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a murine model of Schistosoma mansoni infection Exp Mol Pathol 89 327 333 20858486 10.1016/j.yexmp.2010.09.003 1:CAS:528:DC%2BC3cXhsVans7vN
25. P Carmeliet Y Dor JM Herbert D Fukumura K Brusselmans M Dewerchin M Neeman F Bono R Abramovitch P Maxwell, et al. 1998 Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 394 485 490 9697772 10.1038/28867 1:CAS:528:DyaK1cXltVGqsbg%3D (Pubitemid 28373960)
26. A Lekas AC Lazaris C Deliveliotis M Chrisofos C Zoubouli D Lapas T Papathomas I Fokitis L Nakopoulou 2006 The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue Anticancer Res 26 2989 2993 16886625 1:CAS:528:DC%2BD28XosFaktro%3D (Pubitemid 44161791)
27. Y Nagashima Y Miyagi K Udagawa A Taki K Misugi N Sakai K Kondo S Kaneko M Yao T Shuin 1996 Von Hippel-Lindau tumour suppressor gene. Localization of expression by in situ hybridization J Pathol 180 271 274 8958804 10.1002/(SICI)1096-9896(199611)180:3<271::AID-PATH664>3.0.CO;2-2 1:STN:280:DyaK2s7hsl2hsg%3D%3D (Pubitemid 26393675)
28. CL Corless AS Kibel O Iliopoulos WG Kaelin Jr 1997 Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues Hum Pathol 28 459 464 9104946 10.1016/S0046-8177(97)90035-6 1:STN:280:DyaK2s3lvVOktw%3D%3D (Pubitemid 27175087)
29. J Folkman 1971 Tumor angiogenesis: therapeutic implications N Engl J Med 285 1182 1186 4938153 10.1056/NEJM197108122850711 1:STN:280: DyaE38%2FgvVCqsQ%3D%3D
30. N Weidner PR Carroll J Flax W Blumenfeld J Folkman 1993 Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am J Pathol 143 401 409 7688183 1:STN:280:DyaK3szktlWqtQ%3D%3D (Pubitemid 24058195)
31. N Tanigawa C Lu T Mitsui S Miura 1997 Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance Hepatology 26 1216 1223 9362365 1:STN:280:DyaK1c%2Fis1Krug%3D%3D (Pubitemid 27509306)
32. M Iguchi Y Kakinuma A Kurabayashi T Sato T Shuin SB Hong LS Schmidt M Furihata 2008 Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney Nephron Exp Nephrol 110 e82 e90 18957870 10.1159/000166994 1:CAS:528:DC%2BD1cXhsVaisLnL
33. N Zanesi R Mancini C Sevignani A Vecchione M Kaou M Valtieri GA Calin Y Pekarsky JR Gnarra CM Croce 2005, et al.: Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency Cancer Res 65 6576 6582 16061637 10.1158/0008-5472.CAN-05-1128 1:CAS:528:DC%2BD2MXmvFSltrs%3D (Pubitemid 41060693)